婦人科検診の世界市場規模調査・予測：タイプ別、エンドユーザー別、地域別分析、2022-2029年

婦人科検診の世界市場は、2021年に約205億2,000万米ドルと評価され、2022年から2029年の予測期間中に6.9%以上の健全な成長率で成長すると予測されています。

婦人科検診は、卵巣がん、子宮頸がん、更年期障害、妊娠など、女性に影響を与えるいくつかの疾患のスクリーニング、検査、診断、モニタリングで構成されています。女性の健康に影響を与える病気を診断するために、様々な種類の検査があります。生検装置、イメージング・モニタリング・システム、マンモグラフィ装置などの医療診断機器は、がんの検出、障害物の除去、臓器内部の写真撮影などにより、病気のスクリーニングや診断に役立ちます。診断検査は、卵巣がん、乳がん、子宮頸がん、出生前遺伝子スクリーニング、キャリア検出などの検査で構成されています。さらに、女性におけるがんの発生率の増加や、ポイントオブケア診断検査に対する需要の高まりが、市場成長を促進する主な要因となっています。

長年にわたり、乳がんや卵巣がんを含む様々ながんの発生率は女性の間で著しく増加しており、それゆえ、世界の婦人科検診市場に強い需要を生み出しています。例えば、国際がん研究機関（IARC）によると、2020年には北米で約26600件の卵巣がんが報告され、この数はさらに2030年には30400件、2040年には約33500件に達すると予測されています。また、欧州では2020年に約66600件の卵巣がんが報告され、2030年には70900件、2040年にはさらに72900件に達すると予測されています。また、女性の健康に関連する検査に対する意識の高まりや、主要な市場プレーヤー間の開発・戦略的パートナーシップの増加は、予測期間中に市場に有利な成長見通しをもたらすでしょう。しかし、画像診断システムおよび処置に関連する高いコストは、2022年から2029年の予測期間を通じて市場の成長を妨げます。

婦人科検診の世界市場調査において考慮した主な地域は、アジア太平洋地域、北米、欧州、ラテンアメリカ、その他の地域です。北米は、ブランド製品の優位性により、収益面で市場を独占しており、同地域における女性の診断と画像技術に関連する技術開拓の増加は、予測期間中に市場に有利な機会を提供すると考えられます。アジア太平洋地域は、予測期間中に最も高いCAGRで成長すると予想されていますが、これは、老年人口やターゲット人口の増加、不妊検査モニターの需要の高まり、POC診断やPST診療の急速な受け入れなどの要因により、予測期間中に市場に有利な成長見通しを提供すると考えられます。

市場における最近の動向

• 2022年6月、Mylab Discovery Solutions社は、家庭用妊娠検査キット「PregaScreen」の発売を発表しました。これにより、同社は女性用ヘルスケア市場に参入したことになります。PregaScreenの価格は0.66米ドルで、妊娠を確認することを目的としています。
• 2022年11月、イスラエルに拠点を置く新興企業Salignosticsは、唾液を利用して妊娠を判定する新しい妊娠検査キットSaliStickを発明しました。このキットはイスラエルで発売され、2023年からは世界市場で販売される予定です。

世界市場レポートの範囲

• 過去データ：2019-2020-2021年
• 推計の基準年：2021年
• 予測期間：2022-2029年
• レポート範囲：収益予測、企業ランキング、競合情勢、成長要因、動向
• 地域別範囲：北米、欧州、アジア太平洋地域、ラテンアメリカ、世界のその他地域
• カスタマイズの範囲：レポートカスタマイズ（最大8名分の作業時間）を無料で提供。国別、地域別、セグメント別範囲の追加・変更。

本調査の目的は、近年における様々な分野・国の市場規模を明らかにし、今後数年間の市場規模を予測することです。本レポートは、調査対象国の産業の質的・量的な側面を取り込むよう設計されています。

また、市場の将来的な成長を規定する促進要因や課題など、重要な側面に関する詳細情報も提供しています。さらに、主要企業の競合情勢などの詳細な分析とともに、利害関係者が投資するためのミクロ市場での潜在的な機会も組み込んでいます。

目次

第1章 エグゼクティブサマリー

• マーケットスナップショット
• 世界・セグメント別市場推定・予測、2019年～2029年
  • 婦人科検診市場、地域別、2019-2029年
  • 婦人科検診市場、タイプ別、2019-2029年
  • 婦人科検診市場、エンドユーザー別、2019-2029年
• 主な動向
• 調査手法
• 調査の前提条件

第2章 婦人科検診の世界市場の定義と範囲

• 調査目的
• 市場の定義と範囲
  • 調査対象範囲
  • 産業の進化
• 本調査の対象となった年
• 通貨換算レート

第3章 婦人科検診の世界市場力学

• 婦人科検診市場のインパクト分析（2019-2029年）
  • 市場促進要因
    • 女性のがん罹患率の増加
    • ポイントオブケア診断検査への需要の高まり
  • 市場の課題
    • 画像診断システムおよび処置に関連する高コスト
  • 市場機会
    • 女性の健康関連検査に対する意識の高まり
    • 市場をリードするプレーヤー間の開発および戦略的パートナーシップの数が増加しています

第4章 婦人科検診の世界市場の産業分析

• ポーターの5フォースモデル
  • 供給企業の交渉力
  • 買い手の交渉力
  • 新規参入業者の脅威
  • 代替品の脅威
  • 競争企業間の敵対関係
• ポーターの5フォースモデルへの未来的アプローチ（2019-2029年）
• PEST分析
  • 政治的
  • 経済的
  • ソーシャル
  • テクニカル
• 最高の投資機会
• 主要成功戦略
• 業界関係者見通し
• アナリストの提言と結論

第5章 リスクアセスメント：COVID-19の影響

• COVID-19が業界に与える全体的な影響についての評価
• COVID-19以前とCOVID-19以後の市場シナリオ

第6章 婦人科検診の世界市場：タイプ別

• マーケットスナップショット
• 婦人科検診の世界市場：タイプ別、パフォーマンス別- ポテンシャル分析
• 婦人科検診の世界市場タイプ別推定・予測2019-2029
• 婦人科検診市場、サブセグメント分析
  • 診断用機器
  • 診断検査
  • 付属品・消耗品

第7章 婦人科検診の世界市場：エンドユーザー別

• マーケットスナップショット
• 婦人科検診の世界市場：エンドユーザー別）、パフォーマンス-ポテンシャル分析
• 婦人科検診の世界市場推定・予測（エンドユーザー別） 2019-2029
• 婦人科検診市場、サブセグメント分析
  • 病院・診療所
  • 診断・画像診断センター
  • 在宅ケア
  • その他

第8章 婦人科検診の世界市場：地域別分析

• 婦人科検診市場、地域別市場スナップショット
• 北米
  • 米国
    • タイプ別の推定・予測、2019年～2029年
    • エンドユーザー別の推定・予測、2019年～2029年
  • カナダ
• 欧州の婦人科検診機器市場スナップショット
  • 英国
  • ドイツ
  • フランス
  • スペイン
  • イタリア
  • その他欧州
• アジア太平洋の婦人科検診機器市場スナップショット
  • 中国
  • インド
  • 日本
  • オーストラリア
  • 韓国
  • その他アジア太平洋地域
• ラテンアメリカの婦人科検診市場スナップショット
  • ブラジル
  • メキシコ
  • その他ラテンアメリカ地域
• 世界のその他の地域

第9章 競合情報

• トップ市場戦略
• 企業プロファイル
  • Abbott Laboratories
    • 主要な情報
    • 概要
    • 財務（データの入手が可能な場合のみ）
    • 製品概要
    • 最近の動向
  • Becton, Dickinson and Company
  • Cardinal Health, Inc.
  • F.Hoffmann-La Roche Ltd.
  • General Electric Company
  • Hologic, Inc.
  • Koninklijke Philips N.V.
  • Quest Diagnostics Incorporated
  • Siemens Medical Solutions USA, Inc.
  • bioMerieux SA.

第10章 調査プロセス

• 調査プロセス
  • データマイニング
  • 分析
  • 市場推定
  • バリデーション
  • 出版
• 調査対象者の特徴
• 調査の前提条件

LIST OF TABLES

• TABLE 1. Global Womens Health Diagnostics Market, report scope
• TABLE 2. Global Womens Health Diagnostics Market estimates & forecasts by Region 2019-2029 (USD Billion)
• TABLE 3. Global Womens Health Diagnostics Market estimates & forecasts by Type 2019-2029 (USD Billion)
• TABLE 4. Global Womens Health Diagnostics Market estimates & forecasts by End User 2019-2029 (USD Billion)
• TABLE 5. Global Womens Health Diagnostics Market by segment, estimates & forecasts, 2019-2029 (USD Billion)
• TABLE 6. Global Womens Health Diagnostics Market by region, estimates & forecasts, 2019-2029 (USD Billion)
• TABLE 7. Global Womens Health Diagnostics Market by segment, estimates & forecasts, 2019-2029 (USD Billion)
• TABLE 8. Global Womens Health Diagnostics Market by region, estimates & forecasts, 2019-2029 (USD Billion)
• TABLE 9. Global Womens Health Diagnostics Market by segment, estimates & forecasts, 2019-2029 (USD Billion)
• TABLE 10. Global Womens Health Diagnostics Market by region, estimates & forecasts, 2019-2029 (USD Billion)
• TABLE 11. Global Womens Health Diagnostics Market by segment, estimates & forecasts, 2019-2029 (USD Billion)
• TABLE 12. Global Womens Health Diagnostics Market by region, estimates & forecasts, 2019-2029 (USD Billion)
• TABLE 13. Global Womens Health Diagnostics Market by segment, estimates & forecasts, 2019-2029 (USD Billion)
• TABLE 14. Global Womens Health Diagnostics Market by region, estimates & forecasts, 2019-2029 (USD Billion)
• TABLE 15. U.S. Womens Health Diagnostics Market estimates & forecasts, 2019-2029 (USD Billion)
• TABLE 16. U.S. Womens Health Diagnostics Market estimates & forecasts by segment 2019-2029 (USD Billion)
• TABLE 17. U.S. Womens Health Diagnostics Market estimates & forecasts by segment 2019-2029 (USD Billion)
• TABLE 18. Canada Womens Health Diagnostics Market estimates & forecasts, 2019-2029 (USD Billion)
• TABLE 19. Canada Womens Health Diagnostics Market estimates & forecasts by segment 2019-2029 (USD Billion)
• TABLE 20. Canada Womens Health Diagnostics Market estimates & forecasts by segment 2019-2029 (USD Billion)
• TABLE 21. UK Womens Health Diagnostics Market estimates & forecasts, 2019-2029 (USD Billion)
• TABLE 22. UK Womens Health Diagnostics Market estimates & forecasts by segment 2019-2029 (USD Billion)
• TABLE 23. UK Womens Health Diagnostics Market estimates & forecasts by segment 2019-2029 (USD Billion)
• TABLE 24. Germany Womens Health Diagnostics Market estimates & forecasts, 2019-2029 (USD Billion)
• TABLE 25. Germany Womens Health Diagnostics Market estimates & forecasts by segment 2019-2029 (USD Billion)
• TABLE 26. Germany Womens Health Diagnostics Market estimates & forecasts by segment 2019-2029 (USD Billion)
• TABLE 27. France Womens Health Diagnostics Market estimates & forecasts, 2019-2029 (USD Billion)
• TABLE 28. France Womens Health Diagnostics Market estimates & forecasts by segment 2019-2029 (USD Billion)
• TABLE 29. France Womens Health Diagnostics Market estimates & forecasts by segment 2019-2029 (USD Billion)
• TABLE 30. Italy Womens Health Diagnostics Market estimates & forecasts, 2019-2029 (USD Billion)
• TABLE 31. Italy Womens Health Diagnostics Market estimates & forecasts by segment 2019-2029 (USD Billion)
• TABLE 32. Italy Womens Health Diagnostics Market estimates & forecasts by segment 2019-2029 (USD Billion)
• TABLE 33. Spain Womens Health Diagnostics Market estimates & forecasts, 2019-2029 (USD Billion)
• TABLE 34. Spain Womens Health Diagnostics Market estimates & forecasts by segment 2019-2029 (USD Billion)
• TABLE 35. Spain Womens Health Diagnostics Market estimates & forecasts by segment 2019-2029 (USD Billion)
• TABLE 36. RoE Womens Health Diagnostics Market estimates & forecasts, 2019-2029 (USD Billion)
• TABLE 37. RoE Womens Health Diagnostics Market estimates & forecasts by segment 2019-2029 (USD Billion)
• TABLE 38. RoE Womens Health Diagnostics Market estimates & forecasts by segment 2019-2029 (USD Billion)
• TABLE 39. China Womens Health Diagnostics Market estimates & forecasts, 2019-2029 (USD Billion)
• TABLE 40. China Womens Health Diagnostics Market estimates & forecasts by segment 2019-2029 (USD Billion)
• TABLE 41. China Womens Health Diagnostics Market estimates & forecasts by segment 2019-2029 (USD Billion)
• TABLE 42. India Womens Health Diagnostics Market estimates & forecasts, 2019-2029 (USD Billion)
• TABLE 43. India Womens Health Diagnostics Market estimates & forecasts by segment 2019-2029 (USD Billion)
• TABLE 44. India Womens Health Diagnostics Market estimates & forecasts by segment 2019-2029 (USD Billion)
• TABLE 45. Japan Womens Health Diagnostics Market estimates & forecasts, 2019-2029 (USD Billion)
• TABLE 46. Japan Womens Health Diagnostics Market estimates & forecasts by segment 2019-2029 (USD Billion)
• TABLE 47. Japan Womens Health Diagnostics Market estimates & forecasts by segment 2019-2029 (USD Billion)
• TABLE 48. South Korea Womens Health Diagnostics Market estimates & forecasts, 2019-2029 (USD Billion)
• TABLE 49. South Korea Womens Health Diagnostics Market estimates & forecasts by segment 2019-2029 (USD Billion)
• TABLE 50. South Korea Womens Health Diagnostics Market estimates & forecasts by segment 2019-2029 (USD Billion)
• TABLE 51. Australia Womens Health Diagnostics Market estimates & forecasts, 2019-2029 (USD Billion)
• TABLE 52. Australia Womens Health Diagnostics Market estimates & forecasts by segment 2019-2029 (USD Billion)
• TABLE 53. Australia Womens Health Diagnostics Market estimates & forecasts by segment 2019-2029 (USD Billion)
• TABLE 54. RoAPAC Womens Health Diagnostics Market estimates & forecasts, 2019-2029 (USD Billion)
• TABLE 55. RoAPAC Womens Health Diagnostics Market estimates & forecasts by segment 2019-2029 (USD Billion)
• TABLE 56. RoAPAC Womens Health Diagnostics Market estimates & forecasts by segment 2019-2029 (USD Billion)
• TABLE 57. Brazil Womens Health Diagnostics Market estimates & forecasts, 2019-2029 (USD Billion)
• TABLE 58. Brazil Womens Health Diagnostics Market estimates & forecasts by segment 2019-2029 (USD Billion)
• TABLE 59. Brazil Womens Health Diagnostics Market estimates & forecasts by segment 2019-2029 (USD Billion)
• TABLE 60. Mexico Womens Health Diagnostics Market estimates & forecasts, 2019-2029 (USD Billion)
• TABLE 61. Mexico Womens Health Diagnostics Market estimates & forecasts by segment 2019-2029 (USD Billion)
• TABLE 62. Mexico Womens Health Diagnostics Market estimates & forecasts by segment 2019-2029 (USD Billion)
• TABLE 63. RoLA Womens Health Diagnostics Market estimates & forecasts, 2019-2029 (USD Billion)
• TABLE 64. RoLA Womens Health Diagnostics Market estimates & forecasts by segment 2019-2029 (USD Billion)
• TABLE 65. RoLA Womens Health Diagnostics Market estimates & forecasts by segment 2019-2029 (USD Billion)
• TABLE 66. Row Womens Health Diagnostics Market estimates & forecasts, 2019-2029 (USD Billion)
• TABLE 67. Row Womens Health Diagnostics Market estimates & forecasts by segment 2019-2029 (USD Billion)
• TABLE 68. Row Womens Health Diagnostics Market estimates & forecasts by segment 2019-2029 (USD Billion)
• TABLE 69. List of secondary sources, used in the study of global Womens Health Diagnostics Market
• TABLE 70. List of primary sources, used in the study of global Womens Health Diagnostics Market
• TABLE 71. Years considered for the study
• TABLE 72. Exchange rates considered

List of tables and figures and dummy in nature, final lists may vary in the final deliverable

LIST OF FIGURES

List of figures

• FIG 1. Global Womens Health Diagnostics Market, research methodology
• FIG 2. Global Womens Health Diagnostics Market, Market estimation techniques
• FIG 3. Global Market size estimates & forecast methods
• FIG 4. Global Womens Health Diagnostics Market, key trends 2021
• FIG 5. Global Womens Health Diagnostics Market, growth prospects 2022-2029
• FIG 6. Global Womens Health Diagnostics Market, porters 5 force model
• FIG 7. Global Womens Health Diagnostics Market, pest analysis
• FIG 8. Global Womens Health Diagnostics Market, value chain analysis
• FIG 9. Global Womens Health Diagnostics Market by segment, 2019 & 2029 (USD Billion)
• FIG 10. Global Womens Health Diagnostics Market by segment, 2019 & 2029 (USD Billion)
• FIG 11. Global Womens Health Diagnostics Market by segment, 2019 & 2029 (USD Billion)
• FIG 12. Global Womens Health Diagnostics Market by segment, 2019 & 2029 (USD Billion)
• FIG 13. Global Womens Health Diagnostics Market by segment, 2019 & 2029 (USD Billion)
• FIG 14. Global Womens Health Diagnostics Market, regional snapshot 2019 & 2029
• FIG 15. North America Womens Health Diagnostics Market 2019 & 2029 (USD Billion)
• FIG 16. Europe Womens Health Diagnostics Market 2019 & 2029 (USD Billion)
• FIG 17. Asia pacific Womens Health Diagnostics Market 2019 & 2029 (USD Billion)
• FIG 18. Latin America Womens Health Diagnostics Market 2019 & 2029 (USD Billion)
• FIG 19. Global Womens Health Diagnostics Market, company Market share analysis (2021)

List of tables and figures and dummy in nature, final lists may vary in the final deliverable

Global Women's Health Diagnostics Market is valued approximately USD 20.52 billion in 2021 and is anticipated to grow with a healthy growth rate of more than 6.9 % over the forecast period 2022-2029. Women's Health Diagnostics comprised of screening, testing, or diagnosing, and monitoring of several disorders affecting women such as ovarian cancer, cervical cancer, menopause, and pregnancy among others. There are various test kinds available to diagnose illnesses affecting women's health. Medical diagnostic tools including biopsy machines, imaging and monitoring systems, mammography machines, and others help with illness screening and diagnosis by detecting cancer, clearing obstructions, and taking pictures of inside organs. The diagnostic test comprises examinations for ovarian cancer, breast cancer, cervical cancer, prenatal genetic screening, and carrier detection. Moreover, the increasing incidence of cancers among women and growing demand for the point of care diagnostic testing are key factors driving the market growth.

Over the years the incidents of various cancers including breast and ovarian has significantly increased among female, hence creating strong demand for the Global Womens Health Diagnostics Market. For instance - as per the International Agency for Research on Cancer (IARC) - in 2020, in North America around 26600 cases of ovarian cancers were reported, and this number is further projected to reach to 30400 in 2030, and around 33500 in 2040. Additionally, in Europe around 66600 cases of ovarian cancer were reported in 2020, and this number is projected to reach to 70900 in 2030, and further 72900 in 2040. Also, growing awareness about women's health-related tests as well as rising number of developments and strategic partnerships between leading market players would create lucrative growth prospectus for the market over the [projected period. However, high Cost associated with diagnostic imaging systems and procedures hinders the market growth throughout the forecast period of 2022-2029.

The key regions considered for the Global Women's Health Diagnostics Market study includes Asia Pacific, North America, Europe, Latin America, and Rest of the World. North America dominated the market in terms of revenue, owing to the dominance of branded products and the increasing number of technological developments related to diagnosis of women and imaging techniques in the region would offer lucrative opportunity for the market during the projected period. Whereas Asia Pacific is expected to grow with a highest CAGR during the forecast period, owing to factors such as rising geriatric and target populations, and rising demand for fertility testing monitors coupled with rapid acceptance of POC diagnostics and PST practices in the region would offer lucrative growth prospectus for the market over the projected period.

Major market players included in this report are:

• Abbott Laboratories
• Becton, Dickinson and Company
• Cardinal Health, Inc.
• F. Hoffmann-La Roche Ltd.
• General Electric Company
• Hologic, Inc.
• Koninklijke Philips N.V.
• Quest Diagnostics Incorporated
• Siemens Medical Solutions USA, Inc.
• bioMerieux SA.

Recent Developments in the Market:

• In June 2022, Mylab Discovery Solutions announced launch of PregaScreen, an at-home pregnancy test kit. This marks the company's entry into the female healthcare market. PregaScreen, priced at USD 0.66, intended to confirmation of pregnancy.
• In November 2022, An Israel-based start-up named Salignostics has invented a novel pregnancy test kit - SaliStick, that make use of the saliva to determine pregnancy. The kit has been launched in Israel and would be available in the global markets from 2023.

Global Womens Health Diagnostics Market Report Scope:

• Historical Data: 2019-2020-2021

• Base Year for Estimation: 2021

• Forecast period: 2022-2029

• Report Coverage: Revenue forecast, Company Ranking, Competitive Landscape, Growth factors, and Trends

• Segments Covered: Type, End User, Region

• Regional Scope: North America; Europe; Asia Pacific; Latin America; Rest of the World

• Customization Scope: Free report customization (equivalent up to 8 analyst's working hours) with purchase. Addition or alteration to country, regional & segment scope*

The objective of the study is to define market sizes of different segments & countries in recent years and to forecast the values to the coming years. The report is designed to incorporate both qualitative and quantitative aspects of the industry within countries involved in the study.

The report also caters detailed information about the crucial aspects such as driving factors & challenges which will define the future growth of the market. Additionally, it also incorporates potential opportunities in micro markets for stakeholders to invest along with the detailed analysis of competitive landscape and product offerings of key players. The detailed segments and sub-segment of the market are explained below:

By Type

• Diagnostic Devices
• Diagnostic Tests
• Accessories and Consumables

By End User

• Hospitals and Clinics
• Diagnostic and Imaging Centers
• Homecare
• Others

By Region:

• North America
• U.S.
• Canada
• Europe
• UK
• Germany
• France
• Spain
• Italy
• ROE
• Asia Pacific
• China
• India
• Japan
• Australia
• South Korea
• RoAPAC
• Latin America
• Brazil
• Mexico
• RoLA
• Rest of the World

Table of Contents

Chapter 1. Executive Summary

• 1.1. Market Snapshot
• 1.2. Global & Segmental Market Estimates & Forecasts, 2019-2029 (USD Billion)
  • 1.2.1. Womens Health Diagnostics Market, by Region, 2019-2029 (USD Billion)
  • 1.2.2. Womens Health Diagnostics Market, by Type, 2019-2029 (USD Billion)
  • 1.2.3. Womens Health Diagnostics Market, by End User, 2019-2029 (USD Billion)
• 1.3. Key Trends
• 1.4. Estimation Methodology
• 1.5. Research Assumption

Chapter 2. Global Womens Health Diagnostics Market Definition and Scope

• 2.1. Objective of the Study
• 2.2. Market Definition & Scope
  • 2.2.1. Scope of the Study
  • 2.2.2. Industry Evolution
• 2.3. Years Considered for the Study
• 2.4. Currency Conversion Rates

Chapter 3. Global Womens Health Diagnostics Market Dynamics

• 3.1. Womens Health Diagnostics Market Impact Analysis (2019-2029)
  • 3.1.1. Market Drivers
    • 3.1.1.1. Increasing incidence of cancers among women
    • 3.1.1.2. Growing demand for the point of care diagnostic testing
  • 3.1.2. Market Challenges
    • 3.1.2.1. High Cost associated with diagnostic imaging systems and procedures.
  • 3.1.3. Market Opportunities
    • 3.1.3.1. Growing awareness about women's health-related tests
    • 3.1.3.2. Rising number of developments and strategic partnerships between leading market players

Chapter 4. Global Womens Health Diagnostics Market Industry Analysis

• 4.1. Porter's 5 Force Model
  • 4.1.1. Bargaining Power of Suppliers
  • 4.1.2. Bargaining Power of Buyers
  • 4.1.3. Threat of New Entrants
  • 4.1.4. Threat of Substitutes
  • 4.1.5. Competitive Rivalry
• 4.2. Futuristic Approach to Porter's 5 Force Model (2019-2029)
• 4.3. PEST Analysis
  • 4.3.1. Political
  • 4.3.2. Economical
  • 4.3.3. Social
  • 4.3.4. Technological
• 4.4. Top investment opportunity
• 4.5. Top winning strategies
• 4.6. Industry Experts Prospective
• 4.7. Analyst Recommendation & Conclusion

Chapter 5. Risk Assessment: COVID-19 Impact

• 5.1. Assessment of the overall impact of COVID-19 on the industry
• 5.2. Pre COVID-19 and post COVID-19 Market scenario

Chapter 6. Global Womens Health Diagnostics Market, by Type

• 6.1. Market Snapshot
• 6.2. Global Womens Health Diagnostics Market by Type, Performance - Potential Analysis
• 6.3. Global Womens Health Diagnostics Market Estimates & Forecasts by Type 2019-2029 (USD Billion)
• 6.4. Womens Health Diagnostics Market, Sub Segment Analysis
  • 6.4.1. Diagnostic Devices
  • 6.4.2. Diagnostic Tests
  • 6.4.3. Accessories and Consumables

Chapter 7. Global Womens Health Diagnostics Market, by End User

• 7.1. Market Snapshot
• 7.2. Global Womens Health Diagnostics Market by End User, Performance - Potential Analysis
• 7.3. Global Womens Health Diagnostics Market Estimates & Forecasts by End User 2019-2029 (USD Billion)
• 7.4. Womens Health Diagnostics Market, Sub Segment Analysis
  • 7.4.1. Hospitals and Clinics
  • 7.4.2. Diagnostic and Imaging Centers
  • 7.4.3. Homecare
  • 7.4.4. Others

Chapter 8. Global Womens Health Diagnostics Market, Regional Analysis

• 8.1. Womens Health Diagnostics Market, Regional Market Snapshot
• 8.2. North America Womens Health Diagnostics Market
  • 8.2.1. U.S. Womens Health Diagnostics Market
    • 8.2.1.1. Type breakdown estimates & forecasts, 2019-2029
    • 8.2.1.2. End User breakdown estimates & forecasts, 2019-2029
  • 8.2.2. Canada Womens Health Diagnostics Market
• 8.3. Europe Womens Health Diagnostics Market Snapshot
  • 8.3.1. U.K. Womens Health Diagnostics Market
  • 8.3.2. Germany Womens Health Diagnostics Market
  • 8.3.3. France Womens Health Diagnostics Market
  • 8.3.4. Spain Womens Health Diagnostics Market
  • 8.3.5. Italy Womens Health Diagnostics Market
  • 8.3.6. Rest of Europe Womens Health Diagnostics Market
• 8.4. Asia-Pacific Womens Health Diagnostics Market Snapshot
  • 8.4.1. China Womens Health Diagnostics Market
  • 8.4.2. India Womens Health Diagnostics Market
  • 8.4.3. Japan Womens Health Diagnostics Market
  • 8.4.4. Australia Womens Health Diagnostics Market
  • 8.4.5. South Korea Womens Health Diagnostics Market
  • 8.4.6. Rest of Asia Pacific Womens Health Diagnostics Market
• 8.5. Latin America Womens Health Diagnostics Market Snapshot
  • 8.5.1. Brazil Womens Health Diagnostics Market
  • 8.5.2. Mexico Womens Health Diagnostics Market
  • 8.5.3. Rest of Latin America Womens Health Diagnostics Market
• 8.6. Rest of The World Womens Health Diagnostics Market

Chapter 9. Competitive Intelligence

• 9.1. Top Market Strategies
• 9.2. Company Profiles
  • 9.2.1. Abbott Laboratories
    • 9.2.1.1. Key Information
    • 9.2.1.2. Overview
    • 9.2.1.3. Financial (Subject to Data Availability)
    • 9.2.1.4. Product Summary
    • 9.2.1.5. Recent Developments
  • 9.2.2. Becton, Dickinson and Company
  • 9.2.3. Cardinal Health, Inc.
  • 9.2.4. F.Hoffmann-La Roche Ltd.
  • 9.2.5. General Electric Company
  • 9.2.6. Hologic, Inc.
  • 9.2.7. Koninklijke Philips N.V.
  • 9.2.8. Quest Diagnostics Incorporated
  • 9.2.9. Siemens Medical Solutions USA, Inc.
  • 9.2.10. bioMerieux SA.

Chapter 10. Research Process

• 10.1. Research Process
  • 10.1.1. Data Mining
  • 10.1.2. Analysis
  • 10.1.3. Market Estimation
  • 10.1.4. Validation
  • 10.1.5. Publishing
• 10.2. Research Attributes
• 10.3. Research Assumption